tiprankstipranks
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
KYMR
Kymera Therapeutics
RESEARCH TOOLSreports
Want to see KYMR full AI Analyst Report?

Kymera Therapeutics (KYMR) Income Statement

432 Followers

Kymera Therapeutics Income Statement

Last quarter (Q1 2026), Kymera Therapeutics's total revenue was $34.37M, an increase of 55.50% from the same quarter last year. In Q1, Kymera Therapeutics's net income was $-69.23M. See Kymera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 39.20M$ 47.07M$ 78.59M$ 46.83M$ 72.83M
Gross Profit
$ 39.20M$ 47.07M$ 78.59M$ 46.83M$ 72.83M
Operating Expenses
$ 388.60M$ 308.71M$ 244.12M$ 208.08M$ 173.36M
Depreciation and Amortization
$ 8.31M$ 7.37M$ 3.56M$ 2.98M$ 2.40M
EBITDA
$ -303.06M$ -216.24M$ -143.20M$ -151.66M$ -97.64M
Operating Income
$ -349.40M$ -261.63M$ -165.53M$ -161.26M$ -100.53M
Other Income/Expenses
$ 37.78M$ 37.78M$ 18.57M$ 6.45M$ 313.00K
Pretax Income
$ -311.62M$ -223.86M$ -146.96M$ -154.81M$ -100.22M
Net Income
$ -311.40M$ -223.86M$ -146.96M$ -154.81M$ -100.22M
Per Share Metrics
Basic EPS
$ -3.69$ -2.98$ -2.52$ -2.87$ -2.09
Diluted EPS
$ -3.69$ -2.98$ -2.52$ -2.87$ -2.09
Weighted Average Shares Outstanding
 84.39M 75.04M 58.37M 53.93M 47.99M
Weighted Average Shares Outstanding (Diluted)
 84.39M 75.04M 58.37M 53.93M 47.99M
Currency in USD

Kymera Therapeutics Earnings and Revenue History